GSK (GSK) Inventories, Finished Goods

: $1,842 Mil (As of Dec. 2023)

View and export this data going back to 1987. Start your Free Trial

GSK's quarterly finished goods stayed the same from Jun. 2023 ($0 Mil) to Sep. 2023 ($0 Mil) but then increased from Sep. 2023 ($0 Mil) to Dec. 2023 ($1,842 Mil).

GSK's annual finished goods declined from Dec. 2021 ($2,822 Mil) to Dec. 2022 ($1,564 Mil) but then increased from Dec. 2022 ($1,564 Mil) to Dec. 2023 ($1,842 Mil).

GSK Inventories, Finished Goods Historical Data

The historical data trend for GSK's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Finished Goods

2,944.95

3,267.47

2,821.81

1,563.95

1,841.77

GSK Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Inventories, Finished Goods																1,563.95	-	-	-	1,841.77

GSK Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

GSK (GSK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (NYSE:GSK) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

GLAXF:USA GSK N:Mexico GSKl:UK GSK:UK GS71:Germany GS70:Germany GS71:Germany GS70:Germany GS71:Germany G1SK34:Brazil GSK:Argentina

Address

980 Great West Road, Brentford, Middlesex, GBR, TW8 9GS

Website

https://www.gsk.com

In the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.